Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $5.20 per share for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-09-26
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-09-30 was $5.27, a 32.44% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-09-30 was $7.80, a 338.20% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-09-30 was $1.78, a 24.26% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-09-30 was $2.35, a 44.17% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $5.20, a 26.14% decline from fiscal 2023.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $7.04, a 77.58% decline from fiscal 2022.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $31.40, a 1265.22% increase from fiscal 2021.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $2.30, a 40.24% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $5.20 10-K · filed 2025-09-26 | |||||||
| 2024-03-31 | $5.20 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | $5.18 10-Q · filed 2025-02-12 | |||||||
| 2023-09-30 | $5.27 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | $7.04 10-K · filed 2024-09-19 | |||||||
| 2023-03-31 | $7.71 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | $7.80 10-Q · filed 2024-02-13 | $0.39 10-Q · filed 2023-02-09 | ||||||
| 2022-09-30 | $7.80 10-Q · filed 2023-11-09 | $0.39 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | $31.40 10-K · filed 2023-09-26 | $1.57 10-K · filed 2022-09-08 | ||||||
| 2022-03-31 | $33.00 10-Q · filed 2023-05-11 | $1.65 10-Q · filed 2022-05-23 | ||||||
| 2021-12-31 | $1.78 10-Q · filed 2023-02-09 | |||||||
| 2021-09-30 | $1.78 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | $2.30 10-K · filed 2022-09-08 | |||||||
| 2021-03-31 | $2.32 10-Q · filed 2022-05-23 | |||||||
| 2020-12-31 | $2.30 10-Q/A · filed 2022-05-23 | |||||||
| 2020-09-30 | $2.35 10-Q/A · filed 2022-05-23 | |||||||
| 2020-06-30 | $1.64 10-K · filed 2022-09-08 | $2.50 10-K · filed 2020-09-09 | ||||||
| 2020-03-31 | $1.60 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | $1.60 10-Q · filed 2021-02-04 | |||||||
| 2019-09-30 | $1.63 10-Q · filed 2020-11-10 | |||||||
| 2019-06-30 | $2.78 10-K/A · filed 2022-05-23 | |||||||
| 2019-03-31 | $2.95 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $3.05 10-Q · filed 2020-02-06 | |||||||
| 2018-09-30 | $3.11 10-Q · filed 2019-11-07 | |||||||
| 2018-06-30 | $2.40 10-K · filed 2020-09-09 | |||||||
| 2018-03-31 | $2.10 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $2.19 10-Q · filed 2019-02-07 | |||||||
| 2017-09-30 | $2.21 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | $1.15 10-K · filed 2019-08-28 | |||||||
| 2017-03-31 | $1.12 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $1.12 10-Q · filed 2018-02-08 | |||||||
| 2016-09-30 | $1.12 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | $1.35 10-K · filed 2018-08-30 | |||||||
| 2016-03-31 | $1.35 10-Q · filed 2017-05-04 | |||||||
| 2015-12-31 | $1.38 10-Q · filed 2017-02-08 | |||||||
| 2015-09-30 | $1.38 10-Q · filed 2016-11-09 | |||||||
| 2015-06-30 | $4.81 10-K · filed 2017-09-05 | |||||||
| 2015-03-31 | $5.00 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | $5.24 10-Q · filed 2016-02-05 | |||||||
| 2014-09-30 | $5.15 10-Q · filed 2015-11-06 | |||||||
| 2014-06-30 | $6.85 10-K · filed 2016-09-06 | |||||||
| 2014-03-31 | $6.70 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | $6.65 10-Q · filed 2015-02-06 | |||||||
| 2013-09-30 | $6.68 10-Q · filed 2014-11-06 | |||||||
| 2013-06-30 | $6.57 10-K · filed 2015-09-02 | |||||||
| 2013-03-31 | $6.37 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | $4.47 10-Q · filed 2014-02-11 | |||||||
| 2012-09-30 | $2.76 10-Q · filed 2013-11-08 | $0.46 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | $8.56 10-K · filed 2014-09-09 | $1.43 10-K · filed 2012-09-18 | ||||||
| 2012-03-31 | $8.58 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | $8.58 10-Q · filed 2013-02-12 | |||||||
| 2011-09-30 | $1.66 10-Q · filed 2012-11-13 | |||||||
| 2011-06-30 | $0.98 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |